CD8A and neoplasm: However, the tumor-infiltrating immune cells were quite different: many CD4+ and CD8+ T cells infiltrated ASB-XIV and increased from day 7 to day 14, while only a few T cells infiltrated the LLC1 tumors and decreased from day 7 to day 14.